APMGR also elected Amelia Tataru (general manager of Krka) and Cezar Zaharia (general manager of Sandoz) as its board members. The board is completed by Simona Cocos (general manager of Zentiva) and Artur Banaszak (general manager of Teva).
The association said its top priority is to get authorities to amend the clawback tax, the main obstacle blocking patients’ access to medication and one of the main factors that lead to lower investments in the pharmaceutical sector.
APMGR said the clawback tax led to the disappearance of over 1,300 medicines in Romania in the past three years. The tax also led to the layoff of over 300 employees in the industry and halted planned investments of around EUR50 million.
APMGR represents the main generic medicine producers in Romania: Actavis, AC Helcor, B. Braun Medical, Biofarm, Dr. Reddy’s, Desitin Pharma, Egis, Fresenius Kabi, Gedeon Richter, Glenmark Pharmaceuticals, Infomed Fluids, Krka, Labormed, Magistra CC, Medochemie, Sandoz, Terapia-Ranbaxy, Teva, and Zentiva.